Otlang, Aimee .

HRN: 23-95-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2023
METRONIDAZOLE 500MG (TAB)
10/24/2023
10/30/2023
PO
500mg
TID
THICKLY MSAF
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: